Unprecedented industry milestones achieved with continuous innovation supporting the digital transformation of life sciences SINGAPORE, March 3, 2023 /PRNewswire/ Known for its ground-breaking technological innovations in clinical trials, Medidata, a Dassault Systmes company, has exceeded 30,000 clinical trials and 9 million study participants. These milestones, achieved together with more than 2,100 global customers and partners, have been fueled by Medidata's platform and life sciences solutions that power smarter treatments and healthier people, while driving greater access to trials. "As a patient advocate and study participant, I understand the significance of these milestones," said Anne Marie Mercurio, research advocate and Medidata Patient Insights Board Chair. "And beyond the numbers and the data, Medidata's ongoing commitment to infusing the patient voice into trial designs and solutions, is helping to create a better and more inclusive experience fo
Erin Gilmer, Disability Rights Activist, Dies at 38 nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
12.16.20 FDA s Office Of Minority Health And Health Equity Addresses Patient Diversity
AVROBIO president and CEO Geoff MacKay tells
Business of Biotech about the technology his company is using to drive at-scale gene therapy production for lysosomal disorders and how they overcame a major manufacturing investment that didn t quite work as planned. Listen now and subscribe so you never miss an episode.
Featured Editorial
By Ed Miseta, chief editor, Clinical Leader
The diversity of patients participating in clinical trials continues to be a problem in drug development. As sponsors and sites attempt to address the problem, regulators are also doing their best to address the issue. One person deeply involved in this issue is Rear Admiral Richardae Araojo, the associate commissioner for minority health and director of the Office of Minority Health and Health Equity at the FDA.